Supplementary Table 2 from ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer

MLA

Wafik S. El-Deiry, et al. Supplementary Table 2 from ONC212 Is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22522810.v1.

APA

Wafik S. El-Deiry, Lanlan Zhou, Anna Louie, & Isacco Ferrarini. (2023). Supplementary Table 2 from ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer. https://doi.org/10.1158/1535-7163.22522810.v1

Chicago

Wafik S. El-Deiry, Lanlan Zhou, Anna Louie, and Isacco Ferrarini. 2023. “Supplementary Table 2 from ONC212 Is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer,” April. doi:10.1158/1535-7163.22522810.v1.